Hypertension, serum lipids and cancer risk: A review of epidemiological evidence
about
Analysis of the correlation among hypertension, the intake of β-blockers, and overall survival outcome in patients undergoing chemoradiotherapy with inoperable stage III non-small cell lung cancerObesity, metabolic factors and risk of different histological types of lung cancer: A Mendelian randomization studyDifferent Susceptibilities between Apoe- and Ldlr-Deficient Mice to Inflammation-Associated Colorectal Carcinogenesis.Metabolic syndrome and total cancer mortality in the Third National Health and Nutrition Examination Survey.Immunological consequences of ageing microvascular hemodynamic changes in view of cancer development and treatmentPeriodic Limb Movements in Sleep is Associated with Increased Mortality.A large-scale retrospective study of the overall survival outcome in nasopharyngeal carcinoma with hypertension in Chinese population.Association of diabetes mellitus with thyroid cancer risk: A meta-analysis of cohort studies.Alpha-glucosidase inhibitor use is associated with decreased colorectal neoplasia risk in patients with type 2 diabetes mellitus receiving colonoscopy: a retrospective study.FLT3-ITD, NPM1, and DNMT3A Gene Mutations and Risk Factors in Normal Karyotype Acute Myeloid Leukemia and Myelodysplastic Syndrome Patients in Upper Northern ThailandBlood lipids and lipoproteins in relation to incidence and mortality risks for CVD and cancer in the prospective EPIC-Heidelberg cohort.Lipid profile and dyslipidemia among school-age children in urban Ghana.Lipid Target in Very High-Risk Cardiovascular Patients: Lesson from PCSK9 Monoclonal Antibodies.Differential Tissue Fatty Acids Profiling between Colorectal Cancer Patients with and without Synchronous Metastasis.Preoperative serum lipid profile and outcome in nonmetastatic colorectal cancer.Hypertension predicts a poor prognosis in patients with esophageal squamous cell carcinoma.
P2860
Q33622701-76034757-D1B3-48F2-922D-DB459C052679Q33778268-6F5F9CE2-00FC-4146-AFAF-0C19782C6BDCQ37465413-D3C093F3-1162-4461-84A0-527004FDD5BEQ40376269-AEB9EE14-140A-4028-BC13-C40479B28DDBQ42366660-054E0A68-321B-41F2-BAA1-BA15089F9E6FQ42376216-C48034E9-5E73-448A-A540-8968DA1069D2Q43534303-AB9A3AF3-6FB6-4058-98EB-617FDC41AA64Q47120841-1DBE5D7E-A90D-4D90-B150-9BAB594D8066Q47146612-3CA34501-9588-4095-A0F5-631BE48077ECQ47418833-623A91F5-76D3-4F45-8D6A-4E94190879D4Q49286468-58B05588-4783-4D5E-AAF8-D2DFBD882289Q51245905-FAA99031-FC3A-413C-9C10-262E6D26687AQ51737068-3D052C4A-54AE-4745-8C52-285B0974CB93Q52724684-DBA9B6A5-36BD-435D-AE7D-DFEAC4D83F8FQ55129765-0AE2E049-07FD-4113-8F72-6A26811FD0DEQ55196910-17C39928-9432-4358-9AF1-A4B9258EC4A5
P2860
Hypertension, serum lipids and cancer risk: A review of epidemiological evidence
description
2016 nî lūn-bûn
@nan
2016 թուականին հրատարակուած գիտական յօդուած
@hyw
2016 թվականին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Hypertension, serum lipids and cancer risk: A review of epidemiological evidence
@ast
Hypertension, serum lipids and cancer risk: A review of epidemiological evidence
@en
Hypertension, serum lipids and cancer risk: A review of epidemiological evidence
@nl
type
label
Hypertension, serum lipids and cancer risk: A review of epidemiological evidence
@ast
Hypertension, serum lipids and cancer risk: A review of epidemiological evidence
@en
Hypertension, serum lipids and cancer risk: A review of epidemiological evidence
@nl
prefLabel
Hypertension, serum lipids and cancer risk: A review of epidemiological evidence
@ast
Hypertension, serum lipids and cancer risk: A review of epidemiological evidence
@en
Hypertension, serum lipids and cancer risk: A review of epidemiological evidence
@nl
P1433
P1476
Hypertension, serum lipids and cancer risk: A review of epidemiological evidence
@en
P2093
Eglė Milinavičienė
Irena Kuzmickienė
P356
10.1016/J.MEDICI.2016.03.002
P407
P577
2016-03-10T00:00:00Z